Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds
TR Samatov, AG Tonevitsky, U Schumacher - Molecular cancer, 2013 - Springer
Epithelial-mesenchymal transition (EMT) is a key process in embryonic development and
metastases formation during malignant progression. This review focuses on transcriptional …
metastases formation during malignant progression. This review focuses on transcriptional …
Bladder cancer detection and monitoring: assessment of urine-and blood-based marker tests
S Goodison, CJ Rosser, V Urquidi - Molecular diagnosis & therapy, 2013 - Springer
Bladder cancer is one of the most prevalent cancers worldwide, but the treatment and
management of this disease can be very successful if the disease is detected early. The …
management of this disease can be very successful if the disease is detected early. The …
Label-free reflectometric interference microchip biosensor based on nanoporous alumina for detection of circulating tumour cells
In this report, a label-free reflectometric interference spectroscopy (RIfS) based microchip
biosensor for the detection of circulating tumour cells (CTCs) is demonstrated. Highly …
biosensor for the detection of circulating tumour cells (CTCs) is demonstrated. Highly …
Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis
S Marquardt, M Solanki, A Spitschak, J Vera… - Seminars in cancer …, 2018 - Elsevier
Metastasis is one of the most challenging issues in cancer patient management, and
effective therapies to specifically target disease progression are missing, emphasizing the …
effective therapies to specifically target disease progression are missing, emphasizing the …
Circulating tumour cells in metastatic head and neck cancers
A Kulasinghe, C Perry, L Jovanovic… - … journal of cancer, 2015 - Wiley Online Library
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer with
650,000 new cases p/a worldwide. HNSCC causes high morbidity with a 5‐year survival …
650,000 new cases p/a worldwide. HNSCC causes high morbidity with a 5‐year survival …
[HTML][HTML] Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis
P Gazzaniga, A Gradilone, E De Berardinis… - Annals of …, 2012 - Elsevier
ABSTRACT Background Circulating tumor cells (CTCs) provide prognostic information in
patients with metastatic tumors. Recent studies have shown that CTCs are released in …
patients with metastatic tumors. Recent studies have shown that CTCs are released in …
Circulating tumor cells: overview and opportunities in cytology
KE Sundling, AC Lowe - Advances in anatomic pathology, 2019 - journals.lww.com
Circulating tumor cells (CTCs) have long been assumed to be the substrate of cancer
metastasis. However, only in recent years have we begun to leverage the potential of CTCs …
metastasis. However, only in recent years have we begun to leverage the potential of CTCs …
[HTML][HTML] The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies
Z Zhang, W Fan, Q Deng, S Tang, P Wang, P Xu… - Oncotarget, 2017 - ncbi.nlm.nih.gov
There are inconsistent conclusions in the association between circulating tumor cells (CTCs)
and urothelial cancer (UC). We performed a meta-analysis to assess the prognostic and …
and urothelial cancer (UC). We performed a meta-analysis to assess the prognostic and …
Diagnostic potential of circulating tumor cells, urinary microRNA, and urinary cell-free DNA for bladder cancer: A review
D Koguchi, K Matsumoto, I Shiba, T Harano… - International Journal of …, 2022 - mdpi.com
Early detection of primary bladder cancer (BCa) is vital, because stage and grade have
been generally accepted not only as categorical but also as prognostic factors in patients …
been generally accepted not only as categorical but also as prognostic factors in patients …
Advances in cancer stem cell targeting: How to strike the evil at its root
BM Pützer, M Solanki, O Herchenröder - Advanced drug delivery reviews, 2017 - Elsevier
Cancer progression to metastatic stages is still unmanageable and the promise of effective
anti-metastatic therapy remains largely unmet, emphasizing the need to develop novel …
anti-metastatic therapy remains largely unmet, emphasizing the need to develop novel …